Department of Assisted Reproduction, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, 639 Zhizaoju Rd., Shanghai, 200011, China.
Department of Histology, Embryology, Genetics and Developmental Biology, Shanghai Key Laboratory for Reproductive Medicine, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Arch Gynecol Obstet. 2021 Feb;303(2):565-572. doi: 10.1007/s00404-020-05763-4. Epub 2020 Sep 3.
To study whether the change of endometrial thickness (EMT) between the day of human chorionic gonadotrophin (hCG) administration and the day of embryo transfer has any impact on pregnancy outcome in fresh in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI) cycles.
This single-center retrospective cohort study included 2620 patients undergoing their first consecutive autologous IVF/ICSI cycles from January 2003 to December 2012. Patients were categorized into three groups based on the percentage change of post-hCG EMT: > 10% decrease, ± 10% plateau and > 10% increase. The primary outcome was live birth rate.
Live birth rates were similar in the EMT decrease, plateau and increase groups (27.4% [174/635], 29.7% [300/1010] and 27.6% [269/975]; P = 0.649). Compared with the plateau group, both EMT decrease (crude odds ratio [cOR] 0.89, 95% confidence interval [CI] 0.72-1.11) and increase (cOR 0.90, 95% CI 0.74-1.10) on the day of transfer did not affect the likelihood of live birth. The non-significant association was maintained after controlling for major confounding factors, with the adjusted OR being 0.92 (95% CI 0.73-1.16) and 0.92 (95% CI 0.75-1.13) for the decrease and increase groups, respectively.
EMT change after hCG administration did not provide significant prognostic information for pregnancy outcome in fresh IVF/ICSI cycles. This finding should offer reassuring information for patients with decreased EMT on the day of embryo transfer while questioning the necessity of EMT re-measurement prior to transfer as a routine practice.
研究人绒毛膜促性腺激素(hCG)给药日至胚胎移植日子宫内膜厚度(EMT)的变化对新鲜体外受精/卵胞浆内单精子注射(IVF/ICSI)周期妊娠结局的影响。
本单中心回顾性队列研究纳入了 2003 年 1 月至 2012 年 12 月期间行首次连续自体 IVF/ICSI 周期的 2620 例患者。根据 hCG 后 EMT 的百分比变化,将患者分为三组:下降>10%、±10%平台和增加>10%。主要结局为活产率。
EMT 下降、平台和增加组的活产率相似(27.4%[174/635]、29.7%[300/1010]和 27.6%[269/975];P=0.649)。与平台组相比,移植日 EMT 下降(粗比值比[cOR]0.89,95%置信区间[CI]0.72-1.11)和增加(cOR 0.90,95%CI 0.74-1.10)均不会影响活产的可能性。在控制主要混杂因素后,这种非显著关联仍然存在,调整后的 OR 分别为 0.92(95%CI 0.73-1.16)和 0.92(95%CI 0.75-1.13)。
hCG 给药后 EMT 的变化并不能为新鲜 IVF/ICSI 周期的妊娠结局提供显著的预后信息。这一发现为移植日 EMT 下降的患者提供了令人安心的信息,同时质疑 EMT 测量作为常规操作在移植前重新测量的必要性。